<DOC>
	<DOCNO>NCT00151658</DOCNO>
	<brief_summary>The purpose study evaluate clinical angiographic outcome implantation stent elute elute Sirolimus patient complex coronary artery lesion suitable percutaneous coronary intervention .</brief_summary>
	<brief_title>Sirolimus Eluting Stents Complex Coronary Lesions ( SCANDSTENT )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Stable , unstable angina and/or objective sign myocardial ischaemia Lesions de novo locate native vessel diameter &gt; 2.25 mm . Complex lesion include least one follow characteristic : Ostial location ( &lt; 5 mm ostium ) Total occlusion length ≥ 15 mm Bifurcational ( side branch &gt; 1.75 mm diameter ) Angulated ( &gt; 45° within lesion ) Patients : Other severe disease expect survival &lt; 1 year Other significant cardiac disease Known allergy paclitaxel , clopidogrel stainless steel . Myocardial infarction within 3 day index procedure Linguistic difficulty need interpreter Renal insufficiency ( pcreatinine &gt; 200 micromol/l ) Gastrointestinal bleeding within 1 month Childbearing potential pregnancy Participation another study Lesions : Unprotected leave main disease Restenosis Lesions contain visible thrombus Treatment modality balloon stent ( ablation , brachytherapy , ultrasound ) connection index procedure Diffuse coronary disease distal treat lesion Heavily calcification Lesion locate saphenous vein graft</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Coronary complex lesion</keyword>
	<keyword>Restenosis</keyword>
	<keyword>Drug elute stent</keyword>
</DOC>